Vimarsana
Biggest News Aggregation in the World

Page 26 - Diagnostics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Diagnostics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Diagnostics Inc Today - Breaking & Trending Today

Microbial Identification Methods Market Growth Worth $8.16 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners - Vimarsana News

Microbial Identification Methods Market Growth Worth $8.16 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners

Pune, India, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Microbial identification is the characterization of microbes using a limited spectrum of pre-chosen tests appropriate to the studied problem. Microbial identification

DELFI Diagnostics to Highlight Breakthrough Technology and Completed Clinical Study in Lung Cancer Detection - Vimarsana News

DELFI Diagnostics to Highlight Breakthrough Technology and Completed Clinical Study in Lung Cancer Detection

/PRNewswire/ -- DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to detect cancer, announced today that the company...

Co-Diagnostics, Inc. (NASDAQ:CODX) Short Interest Down 27.4% in September - Vimarsana News

Co-Diagnostics, Inc. (NASDAQ:CODX) Short Interest Down 27.4% in September

Co-Diagnostics, Inc. (NASDAQ:CODX – Get Free Report) was the recipient of a large decline in short interest during the month of September. As of September 15th, there was short interest totalling 581,400 shares, a decline of 27.4% from the August 31st total of 800,500 shares. Based on an average trading volume of 126,900 shares, the […]

Co-Diagnostics, Inc. to Participate in the 2023 UHCA/UCAL Fall Convention & Expo on Sept 27-28 - Vimarsana News

Co-Diagnostics, Inc. to Participate in the 2023 UHCA/UCAL Fall Convention & Expo on Sept 27-28

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...

Global COVID-19 Testing Strategic Business Report 2023-2030 - The Need for Rapid Mass Testing Pushes for Production of Novel Testing Platforms - Vimarsana News

Global COVID-19 Testing Strategic Business Report 2023-2030 - The Need for Rapid Mass Testing Pushes for Production of Novel Testing Platforms

Dublin, Sept. 26, 2023 (GLOBE NEWSWIRE) -- The "COVID-19 Testing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global COVID-19 Testing Market to Reach $5.8 Billion by 2030The global market for COVID-19 Testing estimated at US$24.2 Billion in the year 2022, is projected to reach a revised size of US$5.8 Billion by 2030, growing at a CAGR of -16.3% over the analysis period 2022-2030. The global COVID-19 Testing market is poised for growth, with anti

Source: yahoo.com